CERo Therapeutics Stock Forecast - Sortino Ratio
| CERO Stock | 0.06 0.01 18.57% |
CERo Stock Forecast is based on your current time horizon. Although CERo Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of CERo Therapeutics' systematic risk associated with finding meaningful patterns of CERo Therapeutics fundamentals over time.
CERo |
| Check CERo Therapeutics Volatility | Backtest CERo Therapeutics | Trend Details |
CERo Therapeutics Trading Date Momentum
| On December 12 2024 CERo Therapeutics Holdings, was traded for 0.07 at the closing time. The top price for the day was 0.08 and the lowest listed price was 0.07 . The trading volume for the day was 18.1 M. The trading history from December 12, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 7.89% . The overall trading delta against the current closing price is 6.58% . |
| Compare CERo Therapeutics to competition |
Other Forecasting Options for CERo Therapeutics
For every potential investor in CERo, whether a beginner or expert, CERo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CERo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CERo. Basic forecasting techniques help filter out the noise by identifying CERo Therapeutics' price trends.CERo Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CERo Therapeutics stock to make a market-neutral strategy. Peer analysis of CERo Therapeutics could also be used in its relative valuation, which is a method of valuing CERo Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
CERo Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of CERo Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of CERo Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
CERo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how CERo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CERo Therapeutics shares will generate the highest return on investment. By undertsting and applying CERo Therapeutics stock market strength indicators, traders can identify CERo Therapeutics Holdings, entry and exit signals to maximize returns.
| Accumulation Distribution | 7 M | |||
| Daily Balance Of Power | (0.81) | |||
| Rate Of Daily Change | 0.81 | |||
| Day Median Price | 0.063 | |||
| Day Typical Price | 0.061 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
CERo Therapeutics Risk Indicators
The analysis of CERo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in CERo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cero stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 12.24 | |||
| Semi Deviation | 10.39 | |||
| Standard Deviation | 26.67 | |||
| Variance | 711.28 | |||
| Downside Variance | 138.85 | |||
| Semi Variance | 107.94 | |||
| Expected Short fall | (18.96) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with CERo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CERo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against CERo Stock
| 0.66 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.63 | LLY | Eli Lilly | PairCorr |
| 0.56 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.55 | VALN | Valneva SE ADR | PairCorr |
| 0.53 | INBX | Inhibrx Symbol Change | PairCorr |
The ability to find closely correlated positions to CERo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CERo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CERo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CERo Therapeutics Holdings, to buy it.
The correlation of CERo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CERo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CERo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CERo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of CERo Therapeutics to cross-verify your projections. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.45) |
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.